UK markets open in 3 hours 29 minutes
  • NIKKEI 225

    29,391.19
    +578.59 (+2.01%)
     
  • HANG SENG

    28,420.97
    +2.97 (+0.01%)
     
  • CRUDE OIL

    65.77
    +0.14 (+0.21%)
     
  • GOLD FUTURES

    1,789.30
    +5.00 (+0.28%)
     
  • DOW

    34,230.34
    +97.34 (+0.29%)
     
  • BTC-GBP

    40,879.80
    +1,084.65 (+2.73%)
     
  • CMC Crypto 200

    1,463.92
    +58.61 (+4.17%)
     
  • ^IXIC

    13,582.42
    -51.08 (-0.37%)
     
  • ^FTAS

    4,011.51
    +54.76 (+1.38%)
     

Total Voting Rights

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
  • Oops!
    Something went wrong.
    Please try again later.

Arix Bioscience PLC (ARIX)
04-May-2021 / 07:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

Arix Bioscience plc

 

Total Voting Rights

In conformity with 5.6.1R of the Disclosure Guidance and Transparency Rules, Arix Bioscience plc announces that its total issued share capital at the close of business on 30 April 2021 comprised 135,609,653 Ordinary Shares of 0.001 pence each fully paid. This figure includes 2,311,853 Ordinary Shares which are held in Treasury, leaving a balance of 133,297,800 Ordinary Shares with voting rights.

The above figure of 133,297,800 may be used by shareholders for the calculations by which they will determine if they are required to notify their major interest in, or a change to their major interest in, Arix Bioscience plc under the Disclosure Guidance and Transparency Rules. 

 

[ENDS]

 

For further information, please contact:

 

Arix Bioscience plc

Charlotte Parry, Head of Investor Relations

+44 (0)20 7290 1072

charlotte@arixbioscience.com

 

 

 


ISIN:

GB00BD045071

Category Code:

TVR

TIDM:

ARIX

LEI Code:

213800OVT3AHQCXNIX43

OAM Categories:

2.5. Total number of voting rights and capital

Sequence No.:

102726

EQS News ID:

1191460


 

End of Announcement

EQS News Service

show this
show this